Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Blog Pricing

Clate Mask

๐Ÿ‘ค Speaker
407 total appearances

Appearances Over Time

Podcast Appearances

SaaS Interviews with CEOs, Startups, Founders
637: Reason Infusionsoft Didn't IPO, Passes $100M ARR, $125M Raised, Helping 45,000 SMB's With Marketing and Sales Automation with CEO Clate Mask

Well, no, those are, cause the users are not the paying account customers.

SaaS Interviews with CEOs, Startups, Founders
637: Reason Infusionsoft Didn't IPO, Passes $100M ARR, $125M Raised, Helping 45,000 SMB's With Marketing and Sales Automation with CEO Clate Mask

Those are, those are, you know, you have a, you have a customer number that has two, three, four or five users in the account.

SaaS Interviews with CEOs, Startups, Founders
637: Reason Infusionsoft Didn't IPO, Passes $100M ARR, $125M Raised, Helping 45,000 SMB's With Marketing and Sales Automation with CEO Clate Mask

Oh, I see.

SaaS Interviews with CEOs, Startups, Founders
637: Reason Infusionsoft Didn't IPO, Passes $100M ARR, $125M Raised, Helping 45,000 SMB's With Marketing and Sales Automation with CEO Clate Mask

Um, you know, it's about, it'll tend to be three or four or something like that.

SaaS Interviews with CEOs, Startups, Founders
637: Reason Infusionsoft Didn't IPO, Passes $100M ARR, $125M Raised, Helping 45,000 SMB's With Marketing and Sales Automation with CEO Clate Mask

Yeah.

SaaS Interviews with CEOs, Startups, Founders
637: Reason Infusionsoft Didn't IPO, Passes $100M ARR, $125M Raised, Helping 45,000 SMB's With Marketing and Sales Automation with CEO Clate Mask

The market shifted.

SaaS Interviews with CEOs, Startups, Founders
637: Reason Infusionsoft Didn't IPO, Passes $100M ARR, $125M Raised, Helping 45,000 SMB's With Marketing and Sales Automation with CEO Clate Mask

You know, we, we were, we were getting ready to do that.

SaaS Interviews with CEOs, Startups, Founders
637: Reason Infusionsoft Didn't IPO, Passes $100M ARR, $125M Raised, Helping 45,000 SMB's With Marketing and Sales Automation with CEO Clate Mask

Um,

SaaS Interviews with CEOs, Startups, Founders
637: Reason Infusionsoft Didn't IPO, Passes $100M ARR, $125M Raised, Helping 45,000 SMB's With Marketing and Sales Automation with CEO Clate Mask

Well, a couple of things.

SaaS Interviews with CEOs, Startups, Founders
637: Reason Infusionsoft Didn't IPO, Passes $100M ARR, $125M Raised, Helping 45,000 SMB's With Marketing and Sales Automation with CEO Clate Mask

What's happened over the last, call it seven years, is companies need to be bigger to go public.

SaaS Interviews with CEOs, Startups, Founders
637: Reason Infusionsoft Didn't IPO, Passes $100M ARR, $125M Raised, Helping 45,000 SMB's With Marketing and Sales Automation with CEO Clate Mask

Companies are waiting a lot longer to go public.

SaaS Interviews with CEOs, Startups, Founders
637: Reason Infusionsoft Didn't IPO, Passes $100M ARR, $125M Raised, Helping 45,000 SMB's With Marketing and Sales Automation with CEO Clate Mask

Can you quantify that, Clay?

SaaS Interviews with CEOs, Startups, Founders
637: Reason Infusionsoft Didn't IPO, Passes $100M ARR, $125M Raised, Helping 45,000 SMB's With Marketing and Sales Automation with CEO Clate Mask

$100 million, $200 million?

SaaS Interviews with CEOs, Startups, Founders
637: Reason Infusionsoft Didn't IPO, Passes $100M ARR, $125M Raised, Helping 45,000 SMB's With Marketing and Sales Automation with CEO Clate Mask

$150 is more like what it is today.

SaaS Interviews with CEOs, Startups, Founders
637: Reason Infusionsoft Didn't IPO, Passes $100M ARR, $125M Raised, Helping 45,000 SMB's With Marketing and Sales Automation with CEO Clate Mask

The contact went public at $27 million.

SaaS Interviews with CEOs, Startups, Founders
637: Reason Infusionsoft Didn't IPO, Passes $100M ARR, $125M Raised, Helping 45,000 SMB's With Marketing and Sales Automation with CEO Clate Mask

That kind of gives you a sense for how much it's changed in the last eight, nine years.

SaaS Interviews with CEOs, Startups, Founders
637: Reason Infusionsoft Didn't IPO, Passes $100M ARR, $125M Raised, Helping 45,000 SMB's With Marketing and Sales Automation with CEO Clate Mask

So what really is happening is private money is a lot easier to raise.

SaaS Interviews with CEOs, Startups, Founders
637: Reason Infusionsoft Didn't IPO, Passes $100M ARR, $125M Raised, Helping 45,000 SMB's With Marketing and Sales Automation with CEO Clate Mask

And a lot of times, what historically was the case where public valuations were better than private valuations, that switched for a number of reasons over the last few years.

SaaS Interviews with CEOs, Startups, Founders
637: Reason Infusionsoft Didn't IPO, Passes $100M ARR, $125M Raised, Helping 45,000 SMB's With Marketing and Sales Automation with CEO Clate Mask

And so late stage companies are able to raise private capital.

SaaS Interviews with CEOs, Startups, Founders
637: Reason Infusionsoft Didn't IPO, Passes $100M ARR, $125M Raised, Helping 45,000 SMB's With Marketing and Sales Automation with CEO Clate Mask

So we did that.